content

Omicron Variant Descendants Begin Their Own Coronavirus Wave

The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessingย an upsurge,...

Pfizer Holding To $22B Paxlovid Sales Plan Amid Slow Sales

Pfizer officials stated on an earnings callย that while Paxlovid's first-quarter sales may seem to be low, there will be plenty more revenues in the...

Paradigm4 Launches Reveal: Proteomics to Transform the Search for Protein Isoform Biomarkers

Paradigm4 has unveiled REVEALTM: Proteomics, the newest use case specific app powered by the Paradigm4 FLASHTM high-performance bioinformatics platform. REVEAL: Proteomics unlocks the power of...

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA,...

Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger

New analysis from Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has found that since 2014 the number of...

Teva Settlement Stalls Austedo Generic Rollout Till 2033

Austedo, Teva's tardive dyskinesia (TD) therapy, has great prospects. Now the company only needs to worry about one less generic pharmaceutical presenting a threat...

60% Adults And 75% Kids Have COVID-19 Antibodies- CDC Study

According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read